Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-08-01-2012
Volume2012 Supplement
Issue 4

Pharmaceutical Technology, Outsourcing Resources Supplement 2012 (PDF)

Outsourcing Resources

External Link - article-806906.pdf

Articles in this issue
Pharmaceutical Technology, Outsourcing Resources Supplement 2012 (PDF)
A Manufacturing Capacity-Sharing Model: Merck & Co. and MedImmune LLC
A Manufacturing Capacity-Sharing Model: Merck & Co. and MedImmune LLC
Size Associations in the CRO Outsourcing Relationship
Size Associations in the CRO Outsourcing Relationship
Market Strengths and Weaknesses in Biosimilars
Market Strengths and Weaknesses in Biosimilars
Quality by Design: A Contract Organization's Perspective
Quality by Design: A Contract Organization's Perspective
Strategies in Outsourcing Facilities Management
Strategies in Outsourcing Facilities Management
Strategies in Outsourcing: Insourcing Emerges as an Alternative Model
Strategies in Outsourcing: Insourcing Emerges as an Alternative Model
CROs and CMOs Have Cause to Celebrate
CROs and CMOs Have Cause to Celebrate

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Related Content
Futuristic health tech. A smartwatch projects a holographic health dashboard, providing real-time body analytics and vital signs monitoring anytime, anywhere. | Image Credit: © woravut - stock.adobe.com
August 5th 2025

How FDA’s ISTAND Initiative Supports Innovative Tools in Drug Discovery and Development

Patrick Lavery
The program has been transitioned to a permanent pathway that is designed to support innovative tools like artificial intelligence, wearables, and biomarkers in drug development and trials.
Drug Solutions Podcast: Sustainable Solutions for Biopharma
August 5th 2025

Drug Solutions Podcast: Sustainable Solutions for Biopharma

Patrick Lavery
In this podcast episode, we discuss sustainable approaches to such equipment and materials as medical propellants, flow sensor technology, and walk-in chambers, plus the critical role of women in elevating and accelerating development in these areas.
Site Logo
August 5th 2025

Accelerate drug development with innovative 360˚ CDMO and CRO solutions: A comprehensive guide to streamlining drug development and reducing time to market

Patheon
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
August 5th 2025

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Site Logo
August 5th 2025

Value reimagined: Unlocking ROI and efficiency in drug development

Patheon
White House | Image Credit: © Zack Frank - stock.adobe.com
August 5th 2025

Trump Sends Letters to 17 Leading Pharma Companies Outlining Most-Favored-Nation Drug Pricing Protocol

Patrick Lavery
If action is not taken within 60 days, the White House said it would “deploy every tool in our arsenal” to improve drug pricing practices for American patients.